Company intelligence

Frazier Life Sciences Acquisition Corp. II

BiotechActive

Is this your company? Get featured or correct your listing →

Suggest a correction

We're still building this profile — here is what Pulse has covered.

Latest Pulse

  1. TCGX Acquisition Pops 12% In $100M SPAC IPO DebutTCGX Acquisition Corp II priced a $100 million stock-only SPAC IPO and opened 12% higher at $11.20 in its Nasdaq debut under ticker TCXB, as blank-check vehicles see renewed demand in 2026.→
  2. Frazier Life Sciences II Prices $75M IPO, Lists FLSCFrazier Life Sciences Acquisition Corp. II priced its $75M IPO at $10 a share, with shares beginning Nasdaq trading under ticker FLSC on October 14.→

Coverage Timeline

newest first
  1. Oct 14, 2026IPOFrazier Life Sciences II Prices $75M IPO, Lists FLSC$75M IPO→

All Coverage

IPO

Frazier Life Sciences II Prices $75M IPO, Lists FLSC

Illustration for: Frazier Life Sciences II Prices $75M IPO, Lists FLSC
IPO$75M IPO

Frazier Life Sciences II Prices $75M IPO, Lists FLSC

Frazier Life Sciences Acquisition Corp. II priced its $75M IPO at $10 a share, with shares beginning Nasdaq trading under ticker FLSC on October 14.

DEEP DIVE

Related Companies

Same sector
Scribe TherapeuticsAttovia TherapeuticsApnimedRetension PharmaceuticalsBraveheart BioEli Lilly